glipizide/metformin (Metaglip has been discontinued in the US)

Pharmacy Author:
Medical and Pharmacy Editor:

GENERIC NAME: glipizide/metformin hydrochloride

BRAND NAME: None

DISCONTINUED BRAND: Metaglip

PRESCRIPTION: Yes

GENERIC AVAILABLE: Yes

USES: Glipizide/metformin is used as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes.

SIDE EFFECTS: The most common side effects associated with glipizide/metformin treatment are:

Side effects related to the stomach were most commonly reported by patients who newly started treatment with glipizide/metformin and included:

Other less common but potentially serious side effects include:

Metformin can cause a rare but serious condition known as lactic acidosis, a build-up of acid in the blood. Lactic acidosis can cause death and requires immediate treatment.

Symptoms of lactic acidosis include:

Patients suspected of presenting with signs or symptoms of lactic acidosis must seek emergency medical help.

Medically Reviewed by a Doctor on 5/19/2016



Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index

Health Solutions From Our Sponsors